WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care

Systems medicine approach to optimise drugs and drug combinations for individual AML patients

Work of the WIN consortium and challenges of personalised cancer therapy

Tumour-infiltrating immune cells as classifiers and predictors of outcome

Proactive P4 medicine making blood a window into health and disease

Molecular investigations of immune cells and tumour environment: The ovarian cancer model

Growing tissue stem cells into organoids and tumeroids: Predictive assay development

Combining immunological and targeted agents in melanoma

Cancer stem cells and malignant progression

Colorectal cancer screening and the EORTC SPECTA initiative

microRNA replacement in malignant pleural mesothelioma

Personalised cancer medicine using the human protein atlas and affibodies